JPMorgan Chase & Co’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957 | Buy |
|
|||||
|
2025
Q1 | $810 | Sell |
|
|||||
|
2024
Q4 | $79.9K | Buy |
|
|||||
|
2024
Q3 | $1.29K | Sell |
|
|||||
|
2024
Q2 | $1.91K | Sell |
|
|||||
|
2024
Q1 | $27.5K | Sell |
|
|||||
|
2023
Q4 | $43.8K | Sell |
|
|||||
|
2023
Q3 | $1.14M | Sell |
|
|||||
|
2023
Q2 | $2.65M | Sell |
|
|||||
|
2023
Q1 | $3.4M | Buy |
|
|||||
|
2022
Q4 | $7.54M | Buy |
|
|||||
|
2022
Q3 | $9.11M | Sell |
|
|||||
|
2022
Q2 | $9.11M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $293K | Buy |
|
|||||
|
2021
Q3 | $144K | Sell |
|
|||||
|
2021
Q2 | $136K | Buy |
|
|||||
|
2021
Q1 | $70K | Sell |
|
|||||
|
2020
Q4 | $72K | Sell |
|
|||||
|
2020
Q3 | $124K | Buy |
|
|||||
|
2020
Q2 | $115K | Buy |
|
|||||
|
2020
Q1 | $44K | Sell |
|
|||||
|
2019
Q4 | $313K | Buy |
|
|||||
|
2019
Q3 | $175K | Buy |
|
|||||
|
2019
Q2 | $275K | Buy |
|
|||||
|
2019
Q1 | $54K | Buy |
|
|||||
|
2018
Q4 | $31K | Buy |
|
|||||
|
2018
Q3 | $26K | Buy |
|